Details of the Drug Reposition

General Information of This Drug (ID: DM0RA8F)

Drug Name
Oleoyl-estrone   DM0RA8F
Synonyms Anti-obesity hormone-based therapy, Manhattan
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Obesity DIS47Y1K 5B81 Phase 2 [1]
Psychotic disorder DIS4UQOT 6A20-6A25 Phase 2 [2]
Alzheimer disease DISF8S70 8A20 Phase 2 [3]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00449202) Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)